121 related articles for article (PubMed ID: 38334732)
21. 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
Hirata T; Kinoshita M; Tamari K; Seo Y; Suzuki O; Wakai N; Achiha T; Umehara T; Arita H; Kagawa N; Kanemura Y; Shimosegawa E; Hashimoto N; Hatazawa J; Kishima H; Teshima T; Ogawa K
J Neurosurg; 2019 Sep; 131(3):676-686. PubMed ID: 30239314
[TBL] [Abstract][Full Text] [Related]
22. [Differential diagnosis of brain gliomas by positron emission tomography using various radiopharmaceuticals].
Kostenikov NA; Tiutin LA; Fadeev NP; Panfilenko AF; Zykov EM; Iliushchenko IuR; Makeeva OIu
Vestn Rentgenol Radiol; 2014; (5):13-8. PubMed ID: 25775890
[TBL] [Abstract][Full Text] [Related]
23. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
[TBL] [Abstract][Full Text] [Related]
24. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
25. Re-evaluation of the diagnostic performance of
Kim D; Chun JH; Kim SH; Moon JH; Kang SG; Chang JH; Yun M
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1678-1684. PubMed ID: 31102001
[TBL] [Abstract][Full Text] [Related]
26. 11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas.
D'Souza MM; Sharma R; Jaimini A; Panwar P; Saw S; Kaur P; Mondal A; Mishra A; Tripathi RP
Clin Nucl Med; 2014 Sep; 39(9):791-8. PubMed ID: 25036022
[TBL] [Abstract][Full Text] [Related]
27. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
[TBL] [Abstract][Full Text] [Related]
28. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
Mahasittiwat P; Mizoe JE; Hasegawa A; Ishikawa H; Yoshikawa K; Mizuno H; Yanagi T; Takagi R; Pattaranutaporn P; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):515-22. PubMed ID: 17900820
[TBL] [Abstract][Full Text] [Related]
29. Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas.
Poetsch N; Woehrer A; Gesperger J; Furtner J; Haug AR; Wilhelm D; Widhalm G; Karanikas G; Weber M; Rausch I; Mitterhauser M; Wadsak W; Hacker M; Preusser M; Traub-Weidinger T
Neuro Oncol; 2018 Feb; 20(3):411-419. PubMed ID: 29016947
[TBL] [Abstract][Full Text] [Related]
30. Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016.
Kebir S; Weber M; Lazaridis L; Deuschl C; Schmidt T; Mönninghoff C; Keyvani K; Umutlu L; Pierscianek D; Forsting M; Sure U; Stuschke M; Kleinschnitz C; Scheffler B; Colletti PM; Rubello D; Rischpler C; Glas M
Clin Nucl Med; 2019 Mar; 44(3):214-220. PubMed ID: 30516675
[TBL] [Abstract][Full Text] [Related]
31. Dynamic study of supratentorial gliomas with L-methyl-11C-methionine and positron emission tomography.
Lilja A; Bergström K; Hartvig P; Spännare B; Halldin C; Lundqvist H; Långstrom B
AJNR Am J Neuroradiol; 1985; 6(4):505-14. PubMed ID: 2992257
[TBL] [Abstract][Full Text] [Related]
32. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
33. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.
Torii K; Tsuyuguchi N; Kawabe J; Sunada I; Hara M; Shiomi S
Ann Nucl Med; 2005 Dec; 19(8):677-83. PubMed ID: 16444993
[TBL] [Abstract][Full Text] [Related]
34. T2-FLAIR mismatch sign correlates with
Ebiko Y; Tamura K; Hara S; Inaji M; Tanaka Y; Nariai T; Ishii K; Maehara T
J Neurooncol; 2023 Aug; 164(1):257-265. PubMed ID: 37589920
[TBL] [Abstract][Full Text] [Related]
35. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours.
Cicuendez M; Lorenzo-Bosquet C; Cuberas-Borrós G; Martinez-Ricarte F; Cordero E; Martinez-Saez E; Castell-Conesa J; Sahuquillo J
Clin Neurol Neurosurg; 2015 Dec; 139():328-33. PubMed ID: 26588352
[TBL] [Abstract][Full Text] [Related]
36. 11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET.
Yamamoto Y; Nishiyama Y; Kimura N; Kameyama R; Kawai N; Hatakeyama T; Kaji M; Ohkawa M
Mol Imaging Biol; 2008 Sep; 10(5):281-7. PubMed ID: 18543041
[TBL] [Abstract][Full Text] [Related]
37. Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography.
Shinozaki N; Uchino Y; Yoshikawa K; Matsutani T; Hasegawa A; Saeki N; Iwadate Y
J Neurosurg; 2011 Jun; 114(6):1640-7. PubMed ID: 21214332
[TBL] [Abstract][Full Text] [Related]
38. The accumulation of 11C-methionine in cerebral glioma patients studied with PET.
Kameyama M; Shirane R; Itoh J; Sato K; Katakura R; Yoshimoto T; Hatazawa J; Itoh M; Ido T
Acta Neurochir (Wien); 1990; 104(1-2):8-12. PubMed ID: 2386094
[TBL] [Abstract][Full Text] [Related]
39. Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.
Kato T; Shinoda J; Nakayama N; Miwa K; Okumura A; Yano H; Yoshimura S; Maruyama T; Muragaki Y; Iwama T
AJNR Am J Neuroradiol; 2008 Jun; 29(6):1176-82. PubMed ID: 18388218
[TBL] [Abstract][Full Text] [Related]
40. A pilot study on EGFR-targeted molecular imaging of PET/CT With 11C-PD153035 in human gliomas.
Sun J; Cai L; Zhang K; Zhang A; Pu P; Yang W; Gao S
Clin Nucl Med; 2014 Jan; 39(1):e20-6. PubMed ID: 24335566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
